Developing Event Sample Clauses

Developing Event. Level Estimates The data in this file can be used to develop national 2009 event level estimates for the U.S. civilian noninstitutionalized population on inpatient hospital stays as well as expenditures, and sources of payment for these stays. Estimates of total stays are the sum of the weight variable (PERWT09F) across relevant event records while estimates of other variables must be weighted by PERWT09F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event Level Estimates Hospital Stays Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)* Total number of inpatient hospital stays (in millions) PERWT09F 28.8 (0.99) 28.6 (0.98) Total number of nights in hospital across all stays (in millions) NUMNIGHX 144.3 (9.48) 143.5 (9.52) Average number of nights per stay NUMNIGHX 5.0 (0.26) 5.0 (0.26) Average number of nights per stay (NUMNIGHX > 0) NUMNIGHX 5.2 (0.27) 5.2 (0.27) Hospital Expenditures Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)* Mean total payments per stay IPXP09X $12,818 ($762.8) $12,915 ($767.3) Mean out-of-pocket payment per stay IPDSF09X +IPFSF09X $464 ($58.5) $468 ($59.0) Mean proportion of total expenditures per stay paid by private insurance (IPDPV09X+ IPFPV09X) /IPXP09X ---------- 0.341 (0.0161) Mean total payments per night (NUMNIGHX > 0) IPXP09X/ NUMNIGHX $4,117 ($178.8) $4,147 ($180.3) * Zero payment events can occur in MEPS for the following reasons: (1) the stay was covered under a flat fee arrangement (flat fee payments are included only on the first event covered by the arrangement), (2) there was no charge for a follow-up stay, (3) the provider was never paid by an individual, insurance plan, or other source for services provided, (4) charges were included in another bill, or (5) the event was paid for through government or privately-funded research or clinical trials.
AutoNDA by SimpleDocs
Developing Event. Level Estimates The data in this file can be used to develop national 2008 event-level estimates for the U.S. civilian noninstitutionalized population on dental visits as well as expenditures, and sources of payment for these visits. The weight assigned to each dental visit reported is the person-level weight of the person who visited the dentist. If a person reported several visits, each visit is assigned that individual’s person-level weight. Estimates of total visits are the sum of the weight variable (PERWT08F) across relevant event records while estimates of other variables must be weighted by PERWT08F to be nationally representative. For example, the appropriate estimate for the mean out-of-pocket payment per dental visit can be represented as follows (the subscript ‘j’ identifies each event and represents a numbering of events from 1 through the total number of events in the file): (∑ Wj Xj)/(∑ Wj), where, Wj = PERWT08Fi (full year person weight for the person associated with event j), and Xj = DVSF08Xj (amount paid by self/family for event j) Estimates and corresponding standard errors (SE) can be derived using an appropriate computer software package for complex survey analysis such as SAS, Stata, SUDAAN or SPSS (xxx.xxxx.xxxx.xxx/xxxxxx_xxxx/xxxxxxxx_xxxxxx.xxx). The tables below contain the correct event-level estimates for several key variables on this file. Estimate of Interest Variable Estimate Estimate Excluding Zero Name (SE) Payment Events (SE) Total number of dental visits PERWT08F 297.8 (8.84) 253.6 (7.44) Proportion of dental visits with DVXP08X 0.852 (0.0054) -------- Selected Event-Level Estimates Visits (in millions) expenditures > 0* *Zero payment events can occur in MEPS for the following reasons: (1) the visit was covered under a flat fee arrangement (flat fee payments are included only on the first event covered by the arrangement), (2) there was no charge for a follow-up visit, (3) the provider was never paid directly for services provided by an individual, insurance plan, or other source, (4) charges were included in another bill, or (5) event was paid through government or privately funded research or clinical trial. Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE) Mean total payments per visit DVXP08X $282 ($6.1) $332 ($7.3) Mean out-of-pocket payment per DVSF08X $140 ($4.7) $165 ($5.7) Mean proportion of total DVPV08X/ expenditures paid by private DVXP08X ------- 0.481 (0.0078) Exp...
Developing Event. Level Estimates The data in this file can be used to develop national 2013 event-level estimates for the U.S. civilian noninstitutionalized population on outpatient visits as well as expenditures, and sources of payment for these visits. Estimates of total visits are the sum of the weight variable (PERWT13F) across relevant event records while estimates of other variables must be weighted by PERWT13F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event-Level Estimates Outpatient Visits Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)** Total number of outpatient visits (including phone call events, in millions)* PERWT13F 138.0 (6.46) 132.4 (6.28) Total number of outpatient visits in person and not by telephone (SEETLKPV=1, in millions) PERWT13F 137.3 (6.42) 132.4 (6.28) Total number of in-person visits to doctor (SEETLKPV=1 & SEEDOC=1, in millions) PERWT13F 56.1 (2.78) 54.1 (2.73) Proportion of outpatient visits with expenditures > 0** OPXP13X 0.959 (0.0045) ------------- Outpatient Expenditures (SEETLKPV = 1) Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)** Mean total payments per visit (all sources) OPXP13X $885 ($71.5) $918 ($74.0) Mean out-of-pocket payment per visit OPDSF13X +OPFSF13X $65 ($5.7) $68 ($5.9) Mean proportion of total expenditures paid by private insurance per visit (OPDPV13X +OPFPV13X) /OPXP13X ------------- 0.364 (0.0161) Expenditures: Physician Visits (SEEDOC = 1 & SEETLKPV = 1) Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)** Mean total payments per visit where person saw medical doctor OPXP13X $1,579 ($162.3) $1,638 ($168.1)
Developing Event. Level Estimates The data in this file can be used to develop national 2013 event-level estimates for the U.S. civilian noninstitutionalized population on inpatient hospital stays as well as expenditures, and sources of payment for these stays. Estimates of total stays are the sum of the weight variable (PERWT13F) across relevant event records while estimates of other variables must be weighted by PERWT13F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event-Level Estimates Hospital Stays Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)*
Developing Event. Level Estimates The data in this file can be used to develop national 2005 event level estimates for the U.S. civilian noninstitutionalized population on prescribed medicine purchases (events) as well as expenditures, and sources of payment for these purchases. Estimates of total purchases are the sum of the weight variable (PERWT05F) across relevant event records while estimates of other variables must be weighted by PERWT05F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event (Purchase) Level Estimates All Prescribed Medicine Purchases Estimate of Interest Variable Name Estimate (SE) Number of purchases (in millions) PERWT05F 3001.4 (80.93) Mean total payments per purchase RXXP05X $71 (1.9) Mean out-of-pocket payment per purchase RXSF05X $28 (0.5) Mean proportion of expenditures paid by private insurance per purchase RXPV05X /RXXP05X 0.268 (0.0055) Example by Drug Type: Statins (TC1S1_1=173 or TC1S1_2=173 or TC1S2_1=173 or TC1S3_1 =173 or TC2S1_1=173 or TC2S1_2=173) Estimate of Interest Variable Name Estimate (SE) Number of purchases (in millions) PERWT05F 173.7 (5.82) Mean total payments per purchase RXXP05X $113 (1.7) Mean annual total payments per person RXXP05X (aggregated across purchases within person) $661 (14.7) Example by Associated Condition: Hypertension (RXICD1X=”401” or RXICD2X=”401” or RXICD3X=”401”) Estimate of Interest Variable Name Estimate (SE) Number of purchases (in millions) PERWT05F 449.9 (14.92) Mean total payments per purchase RXXP05X $51 (0.7) Mean annual total payments per person RXXP05X (aggregated across purchases within person) $526 (10.3)
Developing Event. Level Estimates The data in this file can be used to develop national 2013 event-level estimates for the U.S. civilian noninstitutionalized population on prescribed medicine purchases (events) as well as expenditures, and sources of payment for these purchases. Estimates of total number of purchases are the sum of the weight variable (PERWT13F) across relevant event records while estimates of other variables must be weighted by PERWT13F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event (Purchase) Level Estimates All Prescribed Medicine Purchases Estimate of Interest Variable Name Estimate (SE) Number of purchases (in millions) PERWT13F 3309.8 (90.04) Mean total payments per purchase RXXP13X $93 (2.5) Mean out-of-pocket payment per purchase RXSF13X $15 (0.5) Mean proportion of expenditures paid by private insurance per purchase RXPV13X /RXXP13X 0.150 (0.0053) Example by Drug Type: Statins (TC1S1_1 = 173 or TC1S1_2 = 173 or TC1S2_1 = 173 or TC1S3_1 = 173 or TC2S1_1 = 173 or TC2S1_2 = 173) Estimate of Interest Variable Name Estimate (SE) Number of purchases (in millions) PERWT13F 230.0 (6.86) Mean total payments per purchase RXXP13X $70 (3.2) Mean annual total payments per person RXXP13X (aggregated across purchases within person) $393 (17.9)
Developing Event. Level Estimates The data in this file can be used to develop national 2007 event level estimates for the U.S. civilian noninstitutionalized population on office-based medical provider visits as well as expenditures, and sources of payment for these visits. Estimates of total visits are the sum of the weight variable (PERWT07F) across relevant event records while estimates of other variables must be weighted by PERWT07F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event Level Estimates Office-Based Visits Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)** Total number of office-based medical provider visits (including phone call events*, in millions) PERWT07F 1,510.4 (34.68) 1,426.4 (33.03)
AutoNDA by SimpleDocs
Developing Event. Level Estimates The data in this file can be used to develop national 2010 event level estimates for the U.S. civilian noninstitutionalized population on office-based medical provider visits as well as expenditures, and sources of payment for these visits. Estimates of total visits are the sum of the weight variable (PERWT10F) across relevant event records while estimates of other variables must be weighted by PERWT10F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event-Level Estimates Office-Based Visits Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)**
Developing Event. Level Estimates The data in this file can be used to develop national 2007 event level estimates for the U.S. civilian noninstitutionalized population on office-based medical provider visits as well as expenditures, and sources of payment for these visits. Estimates of total visits are the sum of the weight variable (PERWT07F) across relevant event records while estimates of other variables must be weighted by PERWT07F to be nationally representative. The tables below contain event-level estimates for selected variables. Selected Event Level Estimates Office-Based Visits Estimate of Interest Variable Name Estimate (SE) Estimate Excluding Zero Payment Events (SE)** Total number of office-based medical provider visits (including phone call events*, in millions) PERWT07F 1,510.4 (34.68) 1,426.4 (33.03)

Related to Developing Event

  • Dissolution Event If there is a Dissolution Event before the termination of this Safe, the Investor will automatically be entitled (subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds equal to the Cash-Out Amount, due and payable to the Investor immediately prior to the consummation of the Dissolution Event.

  • Liquidity Event If there is a Liquidity Event before the termination of this Safe, this Safe will automatically be entitled (subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds, due and payable to the Investor immediately prior to, or concurrent with, the consummation of such Liquidity Event, equal to the greater of (i) the Purchase Amount (the “Cash-Out Amount”) or (ii) the amount payable on the number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price (the “Conversion Amount”). If any of the Company’s securityholders are given a choice as to the form and amount of Proceeds to be received in a Liquidity Event, the Investor will be given the same choice, provided that the Investor may not choose to receive a form of consideration that the Investor would be ineligible to receive as a result of the Investor’s failure to satisfy any requirement or limitation generally applicable to the Company’s securityholders, or under any applicable laws. Notwithstanding the foregoing, in connection with a Change of Control intended to qualify as a tax-free reorganization, the Company may reduce the cash portion of Proceeds payable to the Investor by the amount determined by its board of directors in good faith for such Change of Control to qualify as a tax-free reorganization for U.S. federal income tax purposes, provided that such reduction (A) does not reduce the total Proceeds payable to such Investor and (B) is applied in the same manner and on a pro rata basis to all securityholders who have equal priority to the Investor under Section 1(d). In connection with Section 1(b)(i) , the Purchase Amount will be due and payable by the Company to the Investor immediately prior to, or concurrent with, the consummation of the Liquidity Event. If there are not enough funds to pay

  • Required Activities 1. Biometrics measuring blood pressure, weight and height for BMI, fasting cholesterol (total and LDL) and fasting glucose 33% 2. Completion of the online Health Survey 33%

  • Professional Development Activities Professional development activities are activities initiated by individual faculty members or groups of faculty members and may include attendance at conferences, workshops or seminars which facilitate the following:

  • Permitted Activities The Executive shall devote his entire business time, attention and energies to the Business of the Employer and shall not during the Term be engaged (whether or not during normal business hours) in any other business or professional activity, whether or not such activity is pursued for gain, profit or other pecuniary advantage; but this shall not be construed as preventing the Executive from:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!